Roquette Launches New Vegetarian Softgel Capsule Formulations
The first of its kind, Lycagel is made up of pea starch technology.
On Nov. 18, 2020, Roquette, a French plant-based ingredients company and pharmaceutical excipients provider, announced the launch of its pea starch technology, Lycagel, for vegetarian softgel capsule formulations.
The first of its kind, according to the company, the new capsule formulation is made up of carrageenan, a setting agent found in marine macro algae, NEOSORB sorbitol, a plant-based ingredient used for nutraceutical applications, and salt, a company press release said. The new product offers significant capsule strength, seal integrity, quick drying time with no stickiness, fast disintegration, no cross-linking, and higher processing temperature suitability.
“The launch of L[ycagel] marks a new era for softgel formulations and manufacturing. Manufacturers no longer need to compromise on performance when launching a vegetable softgel solution,” said Paul Smaltz, head of Roquette’s Global Pharmaceutical business unit, in the press release. “Designed to be easily adaptable to existing gelatin processes, Lycagel can support businesses in bringing vegetarian alternatives to market quickly, without significant changes to existing operations.”
Source: Roquette
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
